SCHEMBL6416256

SCHEMBL6416256

COc1ccc2c(c1)CC(CCN1CCC(F)C1)=C2Cc1nccnc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 10/20 0.54
HRH1 P35367 10/20 0.54
KCNH2 Q12809 5/20 0.52
CHRM1 P11229 3/20 0.52
DRD2 P14416 2/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
HRH3 Q9Y5N1 4/20 0.35
SLC6A4 P31645 3/20 0.35
DRD1 P21728 1/20 0.34
DRD5 P21918 1/20 0.34
DRD3 P35462 1/20 0.34
ACHE P22303 2/20 0.34
BACE1 P56817 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267589 0.93 CYP2D6 (0.47) CYP2D6HRH1KCNH2CHRM1DRD2
SCHEMBL6267611 0.91 HRH1 (0.54) CYP2D6HRH1KCNH2CHRM1
SCHEMBL6418613 0.91 HRH1 (0.66) CYP2D6HRH1KCNH2CHRM1
SCHEMBL6272284 0.88 HRH1 (0.66) CYP2D6HRH1KCNH2CHRM1HTR2A
SCHEMBL6416305 0.86 HRH1 (0.58) CYP2D6HRH1KCNH2CHRM1DRD2
SCHEMBL6270110 0.84 CYP2D6 (0.47) CYP2D6HRH1KCNH2CHRM1
SCHEMBL6420651 0.81 CYP2D6 (0.65) CYP2D6HRH1KCNH2CHRM1DRD2
SCHEMBL6419544 0.81 HRH1 (0.52) CYP2D6HRH1KCNH2CHRM1DRD2
SCHEMBL6270496 0.80 HRH1 (0.60) CYP2D6HRH1KCNH2CHRM1HTR2A
SCHEMBL6272772 0.78 CYP2D6 (0.48) CYP2D6HRH1KCNH2CHRM1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050277645-A1 Sleep inducing compounds and methods relating thereto NEUROCRINE BIOSCIENCES, INC. (US) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277645-A1 Sleep inducing compounds and methods relating thereto CNR1, CNR2, MTNR1B CYP2D6 74/4885HRH1 104/4885KCNH2 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.